Rogers Corp. (ROG) Jumps Mid-Day Amid Sidoti Upgrade
More News related to ROG
- Inhibition of Cell Migration by Gene Silencing - Measured with the xCELLigence Cell Analysis System from Roche
- Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
- 454 Life Sciences Unveils New Bench Top Sequencer, Significant Improvements to the Genome Sequencer FLX System Including 1,000 bp Reads for 2010
- New Cancer Research Tool: Roche's CIM-Plate 16 Enables Real-Time Analysis of Cell Migration on the xCELLigence System
- Eurofins MWG Operon Joins Roche NimbleGen's Certified Service Provider Program for Targeted Enrichment and Sequencing Services
More News related to Upgrades
- Davenport Upgrades Heinz (HNZ) to Buy
- First Analysis Upgrades Advisory Board Company (ABCO) to Overweight
- Jefferies & Co Upgrades Energy XXI (EXXI) to Hold
- Morgan Stanley Upgrades Iowa Telecom (IWA) to Equalweight
- Fox-Pitt Upgrades Eaton Vance (EV) to Outperform
Shares of Rogers Corp. (NYSE: ROG) spiked sharply higher intraday today as an analyst from Sidoti upgraded the stock from Neutral to Buy.
The stock is now up nearly 8%, most recently trading around $28.29.
Click here to stay up-to-date on all the upgrades/downgrades on shares of Rogers.
Rogers Corporation develops, manufactures, and distributes specialty material-based products and components for fabricators and contract manufacturers that produce components and products for original equipment manufacturers OEMs worldwide.
Related Categories
UpgradesStocks Mentioned
-0.14Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
